PRO-DEX, INC. Notes Payable
PRO-DEX, INC. (PDEX) had Notes Payable of $17.51 million as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:NotesPayable · last filed 2026-09-03
- 2026-06-30: Notes Payable $17.51M.
- 2026-03-31: Notes Payable $18.54M.
- 2025-12-31: Notes Payable $10.51M.
- 2025-09-30: Notes Payable $13.28M.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2026-06-30 | $17.51M 10-K · filed 2026-09-03 | |
| 2026-03-31 | $18.54M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $10.51M 10-Q · filed 2026-01-29 | |
| 2025-09-30 | $13.28M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $15.43M 10-K · filed 2026-09-03 | |
| 2025-03-31 | $18.33M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $16.43M 10-Q · filed 2025-01-30 | |
| 2024-09-30 | $13.53M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $11.96M 10-K · filed 2025-09-04 | $7.54M 10-K · filed 2024-09-05 |
| 2024-03-31 | $7.88M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $8.23M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $8.57M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $8.91M 10-K · filed 2024-09-05 | |
| 2023-03-31 | $9.25M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $9.59M 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $9.92M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $10.25M 10-K · filed 2023-10-13 | |
| 2021-06-30 | $11.54M 10-K · filed 2022-09-08 | |
| 2020-06-30 | $3.28M 10-K · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |